The SARS-CoV-2 IgG II Quant assay is a chemiluminescent microparticle immunoassay (CMIA) used for the qualitative and quantitative determination of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Alinity and ARCHITECT i Systems. The SARS-CoV-2 IgG II Quant assay is to be used as an aid in the diagnosis of SARS-CoV-2 infection in conjunction with clinical presentation and other laboratory tests.

  • An aid in evaluating immune status of infected individuals
  • Monitor antibody response in individuals that have received the COVID-19 vaccine
  • Quantitatively measuring IgG antibodies against the spike receptor-binding domain (RBD) of SARS-CoV-2

The SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy the SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the SARS-CoV-2 IgG II Quant Kit for Detecting SARS-CoV-2 or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top